– FRANCE, Marseille – Volta Medical, a pioneering French-based HealthTech startup, working on novel artificial intelligence algorithms to treat cardiac arrhythmias, today announced that it has successfully raised 23 million Euros in a financing round led by Gilde Healthcare with the participation of existing shareholder Pasteur Mutualité.
Concurrent with the financing, Janke Dittmer, General Partner at Gilde Healthcare, has been nominated as a board member and former medical device industry top executive, Denis Gestin, as an independent board member.
“We are excited to support Volta’s team in bringing a unique solution to address one of the biggest unmet needs in the large and fast-growing electrophysiology market” said Janke Dittmer, General Partner at Gilde Healthcare and new Board member.
The new capital will allow the company to establish its revolutionary FDA-cleared and CE-marked VX1 AI software solution as a new standard of care, pursue further R&D activities and start to roll out commercial activities across the US and Europe. Recruitment for TAILORED-AF, an international multicenter trial has already started. Volta Medical will be welcoming two new Board members.
After developing the first commercially available AI software to help electrophysiologists improve the management of cardiac arrhythmias, Volta Medical is now preparing to transform the way ablation procedures will take place in the future.
Theophile Mohr-Durdez, CEO and co-founder of Volta Medical said: “We are excited to be able to complete our highly ambitious medical program with the start of TAILORED-AF, a new randomized controlled trial. This trial aims to demonstrate how our AI software can help physicians optimize both efficacy and efficiency when performing complex procedures to treat heart rhythm disturbances.”
Atrial fibrillation currently affects over 30 million patients worldwide. This underlines the importance of the TAILORED-AF trial which is likely to result in a breakthrough approach for tackling one of the world’s greatest public health challenges in a more consistent and reproducible manner.
About Volta Medical
Founded by three physicians and a data scientist in 2016 in Marseille, Volta Medical is a HealthTech company developing AI software solutions to assist cardiac electrophysiologists in the operating room. Volta’s overarching goal is to drastically improve cardiac arrhythmia management by developing state-of-the-art, data-driven medical devices based on large databases of procedural data with the highest standards of data protection. Its first product, VX1, assists cardiologists in the real-time identification of specific abnormal electrograms, known as dispersed electrograms.
For more information: https://www.volta-medical.com/
About Gilde Healthcare
Gilde Healthcare is a specialized healthcare investor managing over €1.4 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in fast-growing companies active in digital health, MedTech, and therapeutics. The venture & growth companies are based in Europe and North America.
For more information: https://gildehealthcare.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.